✦ LIBER ✦

Quinolinone-based agonists of S1P1: Use of a N-scan SAR strategy to optimize in vitro and in vivo activity

✍ Scribed by Lewis D. Pennington; Michael D. Croghan; Kelvin K.C. Sham; Alexander J. Pickrell; Paul E. Harrington; Michael J. Frohn; Brian A. Lanman; Anthony B. Reed; Matthew R. Lee; Han Xu; Michele McElvain; Yang Xu; Xuxia Zhang; Michael Fiorino; Michelle Horner; Henry G. Morrison; Heather A. Arnett; Christopher Fotsch; Andrew S. Tasker; Min Wong; Victor J. Cee

Book ID: 113496315
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 480 KB
Volume: 22
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2011.10.085

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacodynamic and Pharmacokinetic Stud

Pharmacodynamic and Pharmacokinetic Studies in Rats of S-8-(2-Furyl)- and R-8-Phenyl-2-(di-n-Propylamino)Tetralin, Two Novel 5-HT1A Receptor Agonists In-vitro with Different Properties In-vivo

✍ HONG YU; YE LIU; HONG B. LI; ARNOLD R. MARTIN; ULI HACKSELL; TOMMY LEWANDER 📂 Article 📅 1997 🏛 Pharmaceutical Press 🌐 English ⚖ 784 KB

Neuroprotective effects of the novel D3/

Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole

✍ Jeffrey N Joyce; Steve Presgraves; Lynn Renish; Sabinne Borwege; Tracy Osredkar; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 870 KB

Correction to Mitogen-Activated Protein

Correction to Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAP-K2) as an Antiinflammatory Target: Discovery and in Vivo Activity of Selective Pyrazolo[1,5- a ]pyrimidine Inhibitors Using a Focused Library and Structure-Based Optimization Approach

✍ Kosugi, Tomomi; Mitchell, Dale R.; Fujino, Aiko; Imai, Minoru; Kambe, Mika; Koba 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 174 KB

The in-vivo effect of bakumondo-to (TJ-2

The in-vivo effect of bakumondo-to (TJ-29), a traditional Japanese medicine used for treatment of chronic airway disease, on cytochrome P450 1A2, xanthine oxidase and N-acetyltransferase 2 activity in man

✍ Junji Saruwatari; Shinichirou Hisaeda; Yoko Higa; Yuko Tomiyasu; Kazuko Nakagawa 📂 Article 📅 2004 🏛 Pharmaceutical Press 🌐 English ⚖ 163 KB

Imidazoquinoxaline Src-Family Kinase p56

Imidazoquinoxaline Src-Family Kinase p56 Lck Inhibitors: SAR, QSAR, and the Discovery of ( S )- N -(2-Chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo- [1,5- a ]pyrido[3,2- e ]pyrazin-6-amine (BMS-279700) as a Potent and Orally Active Inhibitor with Excellent in Vivo Antiinflammatory Activity

✍ Chen, Ping; Doweyko, Arthur M.; Norris, Derek; Gu, Henry H.; Spergel, Steven H.; 📂 Article 📅 2004 🏛 American Chemical Society 🌐 English ⚖ 370 KB

Use of in vitro lipid digestion data to

Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: Studies with halofantrine

✍ Christopher J.H. Porter; Ann Marie Kaukonen; Agnes Taillardat-Bertschinger; Ben 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB 👁 1 views

The relative oral bioavailability (BA) of halofantrine base (Hf) was assessed in male beagle dogs after administration of a medium chain triglyceride (MCT), a long chain triglyceride (LCT), and a blended LCT/MCT lipid solution formulation of Hf (Study 1) and after administration of suspensions of Hf